NSLHD News - August 23 2024

in clinical trials, no matter where they live,” he said. “Encouragingly, the centre will help to accelerate research progress and help find a cure for cancer in this lifetime. “The initial trials will aim to improve outcomes for people with head and neck cancers, breast cancers and upper gastric cancers. “NORTH STAR will be moving quickly to expand enrolment of patients from Sydney to other parts of New South Wales including Coffs Harbour, Port Macquarie and Dubbo.” NSLHD Chief Executive Adjunct Professor Anthony Schembri said the district has some of the best cancer survival rates in

Australia and has been at the forefront of research for more than a century. “NORTH STAR will increase survival rates for Australians living with cancer and accelerate the work already underway at NSLHD alongside other premier institutes,” he said. NORTH Foundation Chief Executive Officer Gilbert Lorquet said Kay and Greg’s passion for philanthropy and their deep empathy for people have set a standard of giving that will hopefully inspire others for years to come. Australians can build upon this legacy and help create a future without cancer by donating to the NORTH Foundation today: northfoundation.org.au/northstar

Professor Chris Ward and Heidi Roland Kenn

Professor Dorothy Keefe, CEO, Cancer Australia

Professor Paul Roach, Dr Sumit Sahni, Professor Anthony Gill, Dr David Chan and Professor Nick Pavlakis

Professor Bob Li, Memorial Sloan Kettering Cancer Centre and Her Excellency Govenor General Sam Mostyn AC

WWW.NSLHD.HEALTH.NSW.GOV.AU

75

Made with FlippingBook - professional solution for displaying marketing and sales documents online